世界のPI3キナーゼ（PI3K）阻害剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5949
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、PI3キナーゼ（PI3K）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（CLL-慢性リンパ性白血病、FL-濾胞性リンパ腫、その他疾患）、用途別市場規模（病院、研究所・研究機関、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・PI3キナーゼ（PI3K）阻害剤の市場動向
・企業の競争状況、市場シェア
・PI3キナーゼ（PI3K）阻害剤の種類別市場規模と予測2016-2027（CLL-慢性リンパ性白血病、FL-濾胞性リンパ腫、その他疾患）
・PI3キナーゼ（PI3K）阻害剤の用途別市場規模と予測2016-2027（病院、研究所・研究機関、クリニック、その他）
・PI3キナーゼ（PI3K）阻害剤の北米市場規模2016-2027（アメリカ、カナダ）
・PI3キナーゼ（PI3K）阻害剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・PI3キナーゼ（PI3K）阻害剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・PI3キナーゼ（PI3K）阻害剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・PI3キナーゼ（PI3K）阻害剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Bayer AG、Gilead Sciences Inc.、Novartis AG、TG Therapeutics Inc.、Verastem Inc.）
・結論

PI3K inhibitors work by inhibiting PI3K enzymes, which helps in signaling the pathway for cellular functions such as growth control, metabolism, and translation initiation.
There is extensive ongoing research on targeted therapies such as PI3K inhibitors with proven efficacy in oncology applications.The significant R&D in prevailing class of therapeutics has given rise to targeted therapies.

Market Analysis and Insights: Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market
The global Phosphoinositide 3-Kinase (PI3K) Inhibitors market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Phosphoinositide 3-Kinase (PI3K) Inhibitors market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Phosphoinositide 3-Kinase (PI3K) Inhibitors market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Phosphoinositide 3-Kinase (PI3K) Inhibitors market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Phosphoinositide 3-Kinase (PI3K) Inhibitors market.

Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Scope and Market Size
Phosphoinositide 3-Kinase (PI3K) Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Phosphoinositide 3-Kinase (PI3K) Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
CLL – Chronic Iymphocytic Ieukemia
FL – Follicular Iymphoma
Other Indications

Segment by Application
hospital
Research Institutes and Research Institutions
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer AG
Gilead Sciences Inc.
Novartis AG
TG Therapeutics Inc.
Verastem Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 CLL – Chronic Iymphocytic Ieukemia
1.2.3 FL – Follicular Iymphoma
1.2.4 Other Indications
1.3 Market by Application
1.3.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 hospital
1.3.3 Research Institutes and Research Institutions
1.3.4 Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Perspective (2016-2027)
2.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Growth Trends by Regions
2.2.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Historic Market Share by Regions (2016-2021)
2.2.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Regions (2022-2027)
2.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Industry Dynamic
2.3.1 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Trends
2.3.2 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Drivers
2.3.3 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Challenges
2.3.4 Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Players by Revenue
3.1.1 Global Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Players by Revenue (2016-2021)
3.1.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Players (2016-2021)
3.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue
3.4 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Concentration Ratio
3.4.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in 2020
3.5 Phosphoinositide 3-Kinase (PI3K) Inhibitors Key Players Head office and Area Served
3.6 Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Solution and Service
3.7 Date of Enter into Phosphoinositide 3-Kinase (PI3K) Inhibitors Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Phosphoinositide 3-Kinase (PI3K) Inhibitors Breakdown Data by Type
4.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Historic Market Size by Type (2016-2021)
4.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Type (2022-2027)

5 Phosphoinositide 3-Kinase (PI3K) Inhibitors Breakdown Data by Application
5.1 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Historic Market Size by Application (2016-2021)
5.2 Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2016-2027)
6.2 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
6.2.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2021)
6.2.2 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2022-2027)
6.2.3 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2027)
6.3 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
6.3.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2021)
6.3.2 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2022-2027)
6.3.3 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2027)
6.4 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country
6.4.1 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2016-2021)
6.4.2 North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2016-2027)
7.2 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
7.2.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2021)
7.2.2 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2022-2027)
7.2.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2027)
7.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
7.3.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2021)
7.3.2 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2022-2027)
7.3.3 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2027)
7.4 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country
7.4.1 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2016-2021)
7.4.2 Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2016-2027)
8.2 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
8.2.1 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2027)
8.3 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
8.3.1 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2027)
8.4 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region
8.4.1 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2016-2027)
9.2 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
9.2.1 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2021)
9.2.2 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2022-2027)
9.2.3 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2027)
9.3 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
9.3.1 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2021)
9.3.2 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2022-2027)
9.3.3 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2027)
9.4 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country
9.4.1 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2016-2021)
9.4.2 Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (2016-2027)
10.2 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type
10.2.1 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2027)
10.3 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application
10.3.1 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2027)
10.4 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country
10.4.1 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.1.4 Bayer AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 Gilead Sciences Inc.
11.2.1 Gilead Sciences Inc. Company Details
11.2.2 Gilead Sciences Inc. Business Overview
11.2.3 Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.2.4 Gilead Sciences Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021)
11.2.5 Gilead Sciences Inc. Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Details
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.3.4 Novartis AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021)
11.3.5 Novartis AG Recent Development
11.4 TG Therapeutics Inc.
11.4.1 TG Therapeutics Inc. Company Details
11.4.2 TG Therapeutics Inc. Business Overview
11.4.3 TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.4.4 TG Therapeutics Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021)
11.4.5 TG Therapeutics Inc. Recent Development
11.5 Verastem Inc.
11.5.1 Verastem Inc. Company Details
11.5.2 Verastem Inc. Business Overview
11.5.3 Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Introduction
11.5.4 Verastem Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021)
11.5.5 Verastem Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of CLL - Chronic Iymphocytic Ieukemia
Table 3. Key Players of FL - Follicular Iymphoma
Table 4. Key Players of Other Indications
Table 5. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Regions (2016-2021)
Table 9. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Regions (2022-2027)
Table 11. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Trends
Table 12. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Drivers
Table 13. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Challenges
Table 14. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Restraints
Table 15. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Players (2016-2021)
Table 17. Global Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors as of 2020)
Table 18. Ranking of Global Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Phosphoinositide 3-Kinase (PI3K) Inhibitors Product Solution and Service
Table 22. Date of Enter into Phosphoinositide 3-Kinase (PI3K) Inhibitors Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Type (2016-2021)
Table 26. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Application (2016-2021)
Table 30. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bayer AG Company Details
Table 63. Bayer AG Business Overview
Table 64. Bayer AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product
Table 65. Bayer AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021) & (US$ Million)
Table 66. Bayer AG Recent Development
Table 67. Gilead Sciences Inc. Company Details
Table 68. Gilead Sciences Inc. Business Overview
Table 69. Gilead Sciences Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product
Table 70. Gilead Sciences Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021) & (US$ Million)
Table 71. Gilead Sciences Inc. Recent Development
Table 72. Novartis AG Company Details
Table 73. Novartis AG Business Overview
Table 74. Novartis AG Phosphoinositide 3-Kinase (PI3K) Inhibitors Product
Table 75. Novartis AG Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021) & (US$ Million)
Table 76. Novartis AG Recent Development
Table 77. TG Therapeutics Inc. Company Details
Table 78. TG Therapeutics Inc. Business Overview
Table 79. TG Therapeutics Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product
Table 80. TG Therapeutics Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021) & (US$ Million)
Table 81. TG Therapeutics Inc. Recent Development
Table 82. Verastem Inc. Company Details
Table 83. Verastem Inc. Business Overview
Table 84. Verastem Inc. Phosphoinositide 3-Kinase (PI3K) Inhibitors Product
Table 85. Verastem Inc. Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021) & (US$ Million)
Table 86. Verastem Inc. Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type: 2020 VS 2027
Figure 2. CLL - Chronic Iymphocytic Ieukemia Features
Figure 3. FL - Follicular Iymphoma Features
Figure 4. Other Indications Features
Figure 5. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application: 2020 VS 2027
Figure 6. hospital Case Studies
Figure 7. Research Institutes and Research Institutions Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Phosphoinositide 3-Kinase (PI3K) Inhibitors Report Years Considered
Figure 11. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Regions: 2020 VS 2027
Figure 14. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Regions (2022-2027)
Figure 15. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Players in 2020
Figure 16. Global Top Phosphoinositide 3-Kinase (PI3K) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Phosphoinositide 3-Kinase (PI3K) Inhibitors as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue in 2020
Figure 18. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Type (2016-2021)
Figure 19. Global Phosphoinositide 3-Kinase (PI3K) Inhibitors Revenue Market Share by Type (2022-2027)
Figure 20. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2016-2027)
Figure 22. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2016-2027)
Figure 23. North America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2016-2027)
Figure 24. United States Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2016-2027)
Figure 28. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2016-2027)
Figure 29. Europe Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2016-2027)
Figure 30. Germany Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Region (2016-2027)
Figure 40. China Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2016-2027)
Figure 48. Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2016-2027)
Figure 49. Latin America Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2016-2027)
Figure 50. Mexico Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Share by Country (2016-2027)
Figure 56. Turkey Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Phosphoinositide 3-Kinase (PI3K) Inhibitors Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Bayer AG Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021)
Figure 60. Gilead Sciences Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021)
Figure 61. Novartis AG Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021)
Figure 62. TG Therapeutics Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021)
Figure 63. Verastem Inc. Revenue Growth Rate in Phosphoinositide 3-Kinase (PI3K) Inhibitors Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Global Janus Kinase (JAK) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5815 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ヤヌスキナーゼ（JAK）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ルキソリチニブ、トファシチニブ、オクラシチニブ、バリシチニブ、ペフィシチニブ）、用途別市場規模（自己免疫疾患、腫瘍）、主要...

世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年）

Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5611 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、BCL-2（B細胞リンパ腫2）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（併用療法、単剤療法）、用途別市場規模（がん、自己免疫疾患、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場規模・現状・予測（2021年-2027年）

Global PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-5932 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オラパリブ、タラゾパリブ）、用途別市場規模（卵巣がん、乳がん、その他）、主要地域別市場規模（北米、アメリ...

世界の血管内皮増殖因子（VEGF）阻害剤市場規模・現状・予測（2021年-2027年）

Global Vascular Endothelial Growth Factor (VEGF) Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-6061 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、血管内皮増殖因子（VEGF）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（VEGF-A阻害剤、VEGF-B阻害剤、VEGF-C阻害剤、VEGF-D阻害剤）、用途別市場規模（腫瘍、眼科）、主要地...

世界のJAK＆PI3Kシグナル伝達経路市場規模・現状・予測（2021年-2027年）

Global JAK and PI3K Signaling Pathway Market Size, Status and Forecast 2021-2027
QFJ1-5814 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、JAK＆PI3Kシグナル伝達経路の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PI3K、ヤヌスキナーゼ療法（阻害剤）、PI3K療法（阻害剤）、JAK・PI3Kシグナル伝達バイオマーカー）、用途別市場...

世界のプロテインキナーゼCイプシロン型市場規模・現状・予測（2021年-2027年）

Global Protein Kinase C Epsilon Type Market Size, Status and Forecast 2021-2027
QFJ1-5970 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、プロテインキナーゼCイプシロン型の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブリオスタチン-1、DHACP-6、VMD-1201、その他）、用途別市場規模（アルコール依存症、頭頸部がん、虚血性脳卒...

世界の上皮成長因子受容体（EGFR）阻害剤市場規模・現状・予測（2021年-2027年）

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, Status and Forecast 2021-2027
QFJ1-5726 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、上皮成長因子受容体（EGFR）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（肺がん、大腸がん、乳がん、その他）、用途別市場規模（病院、研究所、研究機関、診療所、その他）、主要地域別市場規模（北...

世界の副腎皮質ホルモン阻害剤市場規模・現状・予測（2021年-2027年）

Global Adrenal Corticosteroid Inhibitors Market Size, Status and Forecast 2021-2027
QFJ1-3766 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、副腎皮質ホルモン阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オシロドロスタット、メチラポン）、用途別市場規模（病院、ホームケア、専門センター、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の酵素ポリADPリボースポリメラーゼ（PARP）阻害剤市場規模・現状・予測（2021年-2027年）

Global Enzyme Poly ADP Ribose Polymerase (PARP) Inhibitor Market Size, Status and Forecast 2021-2027
QFJ1-4191 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、酵素ポリADPリボースポリメラーゼ（PARP）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ニラパリブ（ゼジュラ）、オラパリブ（リンパルザ）、ルカパリブ（ルブラカ）、タラゾパリブ（タルゼンナ）...

世界のホスホジエステラーゼタイプ5（PDE5）阻害剤市場規模・現状・予測（2021年-2027年）

Global Phosphodiesterase Type 5 (PDE5) Inhibitor Market Size, Status and Forecast 2021-2027
QFJ1-5948 2021年6月 117Pages
QYResearch社発行の本調査レポートでは、ホスホジエステラーゼタイプ5（PDE5）阻害剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（シルデナフィル、タダラフィル、アバナフィル、バルデナフィル）、用途別市場規模（病院、小売薬局、オンライン薬...

世界のJAK＆PI3Kシグナル伝達経路市場規模・現状・予測（2021年-2027年） Therapies related to the JAK and PI3K signaling pathways have the potential to target diseases such as cancer and inflammatory diseases, and no suitable drugs are currently available. Current therapies can reduce the burden of disease, but they cannot be cured. Significant progress has been made in …
世界のヤヌスキナーゼ（JAK）阻害剤市場規模・現状・予測（2021年-2027年） JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy in the treatment of various chronic diseases. The high unmet need for the treatment of graft-versus-host disease (GVHD) has also encouraged market vend…
世界のBCL-2（B細胞リンパ腫2）阻害剤市場規模・現状・予測（2021年-2027年） Bcl-2 (B-cell lymphoma 2), encoded in humans by the BCL2 gene, is the founding member of the Bcl-2 family of regulator proteins that regulate cell death (apoptosis), by either inhibiting (anti-apoptotic) or inducing (pro-apoptotic) apoptosis. Market Analysis and Insights: Global BCL-2 (B-cell lympho…
世界のプロテインキナーゼCイプシロン型市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Protein Kinase C Epsilon Type Market The global Protein Kinase C Epsilon Type market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integ…
世界の副腎皮質ホルモン阻害剤市場規模・現状・予測（2021年-2027年） Adrenal corticosteroid inhibitors are a class of therapeutic drugs that are widely used to treat Cushing's syndrome and certain types of solid tumors, such as breast cancer. It exerts its effect by inhibiting the endogenous synthesis of hormones secreted by the adrenal cortex by interfering with the…